Sophia is bravely fighting a life-threatening complication that developed after an allogeneic stem cell transplant.
Following the transplant, she was diagnosed with Graft-versus-Host Disease (GVHD) — a severe condition that occurs when the donor’s immune cells attack the recipient’s body, in Sophia’s case, her liver. This critical condition requires immediate and ongoing medical care.

For Sophia, daily treatment with Ruxolitinib, a targeted medication, is vital. It helps control the immune response caused by GVHD and reduces inflammation, playing a key role in protecting her organs and stabilizing her health.

Today, Sophia needs our collective support — to keep fighting, healing, and living.
Your help can truly save a life.